NFE2L2 and diabetes mellitus: Metformin (1, 1-dimethylbiguanide hydrochloride, MET) has been demonstrated to exert anti-oxidative and anti-inflammatory activities via activating the Nrf2 pathway in diabetes-associated macrovascular and renal injury (Wu et al., 2016).